Authors
Loading...
Knockdown of TTLL4 increases CD11b expression and alters gene expression in NPM1-mutated AML, suggesting a novel therapeutic strategy.
Ilyas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: